Apple® today announced the iPod® nano (PRODUCT) RED Special Edition. (RED) was created by U2 lead singer, Bono and Bobby Shriver to engage business in the fight against AIDS in Africa by getting the world’s most iconic companies to make uniquely branded products. A portion of the profits from these products goes directly to the Global Fund to fund programs for women and children affected by HIV/AIDS in Africa. The iPod nano (PRODUCT) RED comes in a beautiful red aluminum enclosure and features 24 hours of battery life, Apple’s innovative Click Wheel and an incredibly thin and light design. Apple will contribute $10 from the sale of each iPod nano (PRODUCT) RED to the Global Fund to help fight HIV/AIDS in Africa. Apple will also offer a $25 iTunes® (PRODUCT) RED gift card available for purchase at Apple’s retail and online stores next month.
“We’re ecstatic that Apple is giving their customers the choice to buy a red iPod nano and help women and children affected by HIV/AIDS in Africa,” said Bono, co-founder of (RED). “It's wonderful to see this incredible level of commitment from companies that are willing to lend their creativity in the fight against AIDS in Africa, the greatest health crisis in 600 years.”
“Now customers can buy the best music player in the world and do something to help the world at the same time,” said Steve Jobs, Apple’s CEO. “We’re honored to work with Bono, (RED) and this team to contribute to an incredibly important initiative and help change the way people think about AIDS in Africa.”
The Global Fund to Fight AIDS, Tuberculosis and Malaria was established in 2002, with the support of the world’s leaders and UN Secretary General Kofi Annan, to dramatically increase resources to fight three of the world’s most devastating diseases, and to direct those resources to areas of greatest need by supporting locally-driven strategies. To date, the Global Fund has committed $5.2 billion (US) to more than 363 programs in 131 countries. For more information about (RED) please visit www.joinred.com.
Latest Discussion: 
